David Cavallucci
Royal Brisbane and Women's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David Cavallucci.
British Journal of Surgery | 2013
P. T. W. Kim; Alice Wei; Eshetu G. Atenafu; David Cavallucci; Sean P. Cleary; C.-A. Moulton; Paul D. Greig; Steven Gallinger; Stefano Serra; Ian D. McGilvray
The management of portal vein (PV) involvement by pancreatic adenocarcinoma during pancreaticoduodenectomy (PD) is controversial. The aim of this study was to compare the outcomes of unplanned and planned PV resections as part of PD.
Hpb | 2016
Joel Lewin; Nicholas O'Rourke; Adrian Kah Heng Chiow; Richard Bryant; I. Martin; Leslie Nathanson; David Cavallucci
BACKGROUND This study compares long-term outcomes between intention-to-treat laparoscopic and open approaches to colorectal liver metastases (CLM), using inverse probability of treatment weighting (IPTW) based on propensity scores to control for selection bias. METHOD Patients undergoing liver resection for CLM by 5 surgeons at 3 institutions from 2000 to early 2014 were analysed. IPTW based on propensity scores were generated and used to assess the marginal treatment effect of the laparoscopic approach via a weighted Cox proportional hazards model. RESULTS A total of 298 operations were performed in 256 patients. 7 patients with planned two-stage resections were excluded leaving 284 operations in 249 patients for analysis. After IPTW, the population was well balanced. With a median follow up of 36 months, 5-year overall survival (OS) and recurrence-free survival (RFS) for the cohort were 59% and 38%. 146 laparoscopic procedures were performed in 140 patients, with weighted 5-year OS and RFS of 54% and 36% respectively. In the open group, 138 procedures were performed in 122 patients, with a weighted 5-year OS and RFS of 63% and 38% respectively. There was no significant difference between the two groups in terms of OS or RFS. CONCLUSION In the Brisbane experience, after accounting for bias in treatment assignment, long term survival after LLR for CLM is equivalent to outcomes in open surgery.
Hpb | 2015
Adrian Kah Heng Chiow; Joel Lewin; Bavahuna Manoharan; David Cavallucci; Richard Bryant; Nicholas O'Rourke
BACKGROUND Dome liver lesions (those in segments VII or VIII) pose a challenge to standard laparoscopic resection. The use of additional intercostal and transthoracic trocars (ITTs) potentially facilitates resection over standard subcostal laparoscopic (SSL) techniques. METHODS A retrospective review of a prospectively collected liver resection database was performed, selecting all minor resections of segments VII and VIII using the ITT and SSL approaches. The techniques of intercostal transdiaphragmatic access are described and the surgical outcomes of the two groups compared. RESULTS A total of 19 patients were analysed. The ITT group included 8 patients and the SSL group included 11. The groups were comparable in median lesion size (20 mm in the ITT group and 26 mm in the SSL group). Blood loss, operative times, morbidity and conversion rates were similar. There was no lung injury or postoperative clinical pneumothorax in any patient undergoing transdiaphragmatic access. Median hospital stay was significantly shorter in the ITT group (2 days) than in the SSL group (6 days) (P = 0.032). CONCLUSIONS The ITT approach is safe, effective and complementary to standard laparoscopic techniques for the resection of small tumours in segments VII and VIII.
Hpb | 2015
Matthew Burge; Nick O'Rourke; David Cavallucci; Richard Bryant; Alessandra Francesconi; Kathleen Houston; David Wyld; Melissa Eastgate; Robert Finch; George Hopkins; Paul Thomas; David Macfarlane
BACKGROUND The role of fluorodeoxyglucose (FDG) positron emission tomography (PET/CT) scanning in operable pancreas cancer is unclear. We, therefore, wanted to investigate the impact of PET/CT on management, by incorporating it into routine work-up. METHODS This was a single-institution prospective study. Patients with suspected and potentially operable pancreas, distal bile duct or ampullary carcinomas underwent PET/CT in addition to routine work-up. The frequency that PET/CT changed the treatment plan or prompted other investigations was determined. The distribution of standard uptake values (SUV) among primary tumours, and adjacent to biliary stents was characterised. RESULTS Fifty-six patients were recruited. The surgical plan was abandoned in 9 (16%; 95% CI: 6-26) patients as a result of PET/CT identified metastases. In four patients, metastases were missed and seven were inoperable at surgery, not predicted by PET/CT. Unexpected FDG uptake resulted in seven additional investigations, of which two were useful. Among primary pancreatic cancers, a median SUV was 4.9 (range 2-12.1). SUV was highest around the biliary stent in 17 out of 28 cases. PET/CT detected metastases in five patients whose primary pancreatic tumours demonstrated mild to moderate avidity (SUV < 5). CONCLUSIONS PET/CT in potentially operable pancreas cancer has limitations. However, as a result of its ability to detect metastases, PET/CT scanning is a useful tool in the selection of such patients for surgery.
Clinical Transplantation | 2015
Peter T. W. Kim; Max Marquez; James Jung; David Cavallucci; Eberhard L. Renner; Mark S. Cattral; Paul D. Greig; Ian D. McGilvray; Markus Selzner; Anand Ghanekar; David R. Grant
Long‐term biliary complications after living donor liver transplantation (LDLT) are not well described in the literature. This study was undertaken to determine the long‐term impact of biliary complications after adult right‐lobe LDLT.
Trauma | 2011
Geoffrey Ryan; David Cavallucci
A hernia through an intercostal space involving the bowel is rare but can result in strangulation of the bowel if not diagnosed promptly. We report a case of bowel herniation through the left 9th intercostal space after blunt trauma in a motor vehicle collision. A mass was present overlying the left lower anterolateral chest wall thought to be a haematoma, but it was eventually diagnosed as an intercostal hernia after CT imaging. The treatment for this injury included diagnostic laparoscopy to rule out other abdominal injuries and local repair of the defect. This report discusses the current literature regarding diagnosis and treatment of this rare phenomenon.
Anz Journal of Surgery | 2016
Daniel James Kilburn; Adrian Kah Heng Chiow; Joel Lewin; Nicholas Kienzle; David Cavallucci; Richard Bryant; Nicholas O'Rourke
This report describes the technical aspects and outcomes of a laparoscopic approach in planned two‐stage liver resections for patients with bilobar colorectal cancer (CRC) liver‐only metastases.
Anz Journal of Surgery | 2017
Danielle E. Robson; Joel Lewin; Anthony W. Cheng; Nicholas O'Rourke; David Cavallucci
Metastatic colorectal cancer (mCRC) in pregnancy and post‐partum is rare, but represents significant diagnostic and therapeutic challenges for clinicians. A multidisciplinary team (MDT) approach is essential. This study reports the first series in the Australasian literature, describing our experience with and management of pregnant and post‐partum patients diagnosed with synchronous colorectal liver metastases (sCRLM).
Hepatoma Research | 2016
Daniel J. Kilburn; Universe Leung; David Cavallucci; Cassandra Jeavons; Mehan Siriwardhane; Richard Bryant; Thomas R. O’Rourke; Shinn Yeung; Nicholas A. O’Rourke
Dr. Nicholas A. O’Rourke (Right) and Dr. Daniel J. Kilburn (Left) are co-authors of this paper. Dr. O’Rourke is the Chairman of General Surgery and the Chief of HPB at the Royal Brisbane Hospital (RBH), Brisbane, Queensland, Australia. He is an immediate past President of ANZHPBA and current Secretary-General of the International Laparoscopic Liver Society (ILLS). Dr. Kilburn is a surgical resident at the RBH with a keen interest in laparoscopic HPB surgery. www.hrjournal.net
Pathology | 2018
Gregory Miller; Catherine Campbell; B Manoharan; Richard Bryant; David Cavallucci; Nicholas O'Rourke; Andrew D. Clouston
Hepatocellular adenomas are benign liver lesions with a risk of rupture and malignant transformation. Various molecular subgroups have been identified which appear to have characteristic morphological and immunohistochemical features. We examined the morphology and immunohistochemical profile of a series of 121 HCA from 97 patients to identify the HCA subtypes present and determine the number at risk for malignant transformation according to the World Health Organization (WHO) criteria for hepatocellular adenomas. There were 34 HNF1α inactivated HCA (28%), 61 inflammatory HCA (50%), 15 β-catenin activated HCA (12%) and 11 unclassified adenomas (9%). This proportion of cases was similar to that seen in other series utilising molecular classification. The morphological features of the adenomas were suggestive but not definite indicators of the subtypes present. Morphological features that showed overlap between the subtypes included steatosis within the lesion, a ductular reaction and focal atypia, so that immunohistochemical typing was required for accurate classification. In conclusion, immunohistochemistry is a clinically useful surrogate for identifying underlying molecular changes in the HCA subtypes.